+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Newron Pharmaceuticals SpA - logo
Xadago - Product Thumbnail Image

Xadago

  • Report
  • June 2018
  • 15 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 700 Pages
  • Global
From
Dyskinesia - Pipeline Review, H2 2020 - Product Thumbnail Image

Dyskinesia - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 262 Pages
  • Global
From
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H1 2020 - Product Thumbnail Image

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 92 Pages
  • Global
From
Global Parkinson's Disease Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global Parkinson's Disease Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
  • March 2018
  • Global
From
P2X7 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

P2X7 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 99 Pages
  • Global
From
Newron Pharmaceuticals S.p.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Newron Pharmaceuticals S.p.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Newron Pharmaceuticals SpA (NWRN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Newron Pharmaceuticals SpA (NWRN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • November 2022
  • 53 Pages
From
Loading Indicator